According to SIGA Technologies's latest financial reports the company has $0.19 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.19 B | 15.69% |
2022-12-31 | $0.17 B | -2.38% |
2021-12-31 | $0.17 B | 34.3% |
2020-12-31 | $0.12 B | 32.74% |
2019-12-31 | $97.78 M | -4.99% |
2018-12-31 | $0.10 B | -131.85% |
2017-12-31 | $-0.33 B | 12.43% |
2016-12-31 | $-0.29 B | 1.05% |
2015-12-31 | $-0.29 B | 15.39% |
2014-12-31 | $-0.25 B | -1552.11% |
2013-12-31 | $16.97 M | -39.89% |
2012-12-31 | $28.24 M | -30.73% |
2011-12-31 | $40.77 M | 237.82% |
2010-12-31 | $12.06 M | 68.73% |
2009-12-31 | $7.15 M | 360.11% |
2008-12-31 | $1.55 M | -70.27% |
2007-12-31 | $5.22 M | -28.2% |
2006-12-31 | $7.28 M | 125.37% |
2005-12-31 | $3.23 M | -29.13% |
2004-12-31 | $4.55 M | -17.87% |
2003-12-31 | $5.55 M | 155.46% |
2002-12-31 | $2.17 M | -38.64% |
2001-12-31 | $3.54 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | $0.85 B | 336.52% | ๐บ๐ธ USA |
Novavax NVAX | -$0.72 B | -464.18% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $0.42 B | 118.01% | ๐บ๐ธ USA |
NanoViricides NNVC | $12.45 M | -93.68% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | -$0.46 B | -331.40% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.64 B | 229.83% | ๐บ๐ธ USA |